Crl:SD |
systolic blood pressure |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
arterial blood pressure trait |
male |
63 days-77 days |
9 |
159.0 |
mmHg |
2.0 |
6.0 |
tail cuff plethysmography |
tail |
0.0 |
0 |
F |
75851 |
1540 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
63 days-77 days |
10 |
111.6 |
mg/dl |
1.8 |
5.69 |
liquid phase colorimetry |
|
0.0 |
0 |
FT |
75857 |
1540 |
Crl:SD |
water drink intake rate |
controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
drinking behavior trait |
male |
42 days
| 9 |
34.0 |
ml/d |
0.3 |
0.9 |
unspecified method |
|
0.0 |
0 |
F |
75867 |
1540 |
Crl:SD |
plasma glucagon level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucagon amount |
male |
0 days
| 8 |
402.0 |
pmol/l |
32.0 |
90.51 |
radioimmunoassay |
|
0.0 |
0 |
FT |
75924 |
1540 |
Crl:SD |
metformin drink intake rate |
controlled metformin content drinking water (350-500 mg/kg/d) then controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
drinking behavior trait |
male |
42 days
| 10 |
33.0 |
ml/d |
0.6 |
1.9 |
unspecified method |
|
0.0 |
0 |
metformin drink intake rate |
75869 |
1540 |
Crl:SD |
food intake rate |
controlled metformin content drinking water (350-500 mg/kg/d) then controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
eating behavior trait |
male |
42 days
| 10 |
18.0 |
g/d |
0.3 |
0.95 |
unspecified method |
|
0.0 |
0 |
FT |
75877 |
1540 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) then controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
42 days
| 10 |
104.4 |
mg/dl |
9.0 |
28.46 |
liquid phase colorimetry |
|
0.0 |
0 |
FT |
75861 |
1540 |
Crl:SD |
food intake rate |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
eating behavior trait |
male |
63 days-77 days |
10 |
24.0 |
g/d |
0.4 |
1.26 |
unspecified method |
|
0.0 |
0 |
FT |
75873 |
1540 |
Crl:SD |
food intake rate |
controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
eating behavior trait |
male |
42 days
| 9 |
19.0 |
g/d |
0.3 |
0.9 |
unspecified method |
|
0.0 |
0 |
F |
75875 |
1540 |
Crl:SD |
plasma insulin level |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
63 days-77 days |
9 |
51.0 |
mU/l |
7.0 |
21.0 |
radioimmunoassay |
|
0.0 |
0 |
F |
75847 |
1540 |
Crl:SD |
metformin drink intake rate |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
drinking behavior trait |
male |
63 days-77 days |
10 |
35.0 |
ml/d |
0.4 |
1.26 |
unspecified method |
|
0.0 |
0 |
metformin drink intake rate |
75865 |
1540 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
0 days
| 8 |
102.6 |
mg/dl |
3.6 |
10.18 |
liquid phase colorimetry |
|
0.0 |
0 |
FT |
75921 |
1540 |
Crl:SD |
plasma glucose level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
0 days
| 8 |
82.8 |
mg/dl |
7.2 |
20.36 |
liquid phase colorimetry |
|
0.0 |
0 |
FT |
75922 |
1540 |
Crl:SD |
systolic blood pressure |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
arterial blood pressure trait |
male |
63 days-77 days |
10 |
143.0 |
mmHg |
2.0 |
6.32 |
tail cuff plethysmography |
tail |
0.0 |
0 |
FT |
75853 |
1540 |
Crl:SD |
plasma glucose level |
controlled fructose content diet (66 %) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
42 days
| 9 |
108.0 |
mg/dl |
1.8 |
5.4 |
liquid phase colorimetry |
|
0.0 |
0 |
F |
75859 |
1540 |
Crl:SD |
plasma insulin level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
63 days-77 days |
10 |
32.0 |
mU/l |
4.0 |
12.65 |
radioimmunoassay |
|
0.0 |
0 |
FT |
75849 |
1540 |
Crl:SD |
plasma glucose level |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucose amount |
male |
63 days-77 days |
9 |
117.0 |
mg/dl |
3.6 |
10.8 |
liquid phase colorimetry |
|
0.0 |
0 |
F |
75855 |
1540 |
Crl:SD |
plasma glucagon level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood glucagon amount |
male |
0 days
| 8 |
353.0 |
pmol/l |
27.0 |
76.37 |
radioimmunoassay |
|
0.0 |
0 |
FT |
75923 |
1540 |
Crl:SD |
systolic blood pressure |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
arterial blood pressure trait |
male |
0 days
| 0 |
160.0 |
mmHg |
3.0 |
|
tail cuff plethysmography |
tail |
0.0 |
0 |
F |
75925 |
1540 |
Crl:SD |
systolic blood pressure |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
arterial blood pressure trait |
male |
0 days
| 8 |
158.0 |
mmHg |
3.0 |
8.49 |
tail cuff plethysmography |
tail |
0.0 |
0 |
FT |
75926 |
1540 |
Crl:SD |
plasma insulin level |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
0 days
| 0 |
53.0 |
mU/l |
7.0 |
|
radioimmunoassay |
|
0.0 |
0 |
F |
75879 |
1540 |
Crl:SD |
plasma insulin level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
0 days
| 8 |
68.0 |
mU/l |
3.0 |
8.49 |
radioimmunoassay |
|
0.0 |
0 |
FT |
75880 |
1540 |
Crl:SD |
food intake rate |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
eating behavior trait |
male |
63 days-77 days |
9 |
26.0 |
g/d |
1.7 |
5.1 |
unspecified method |
|
0.0 |
0 |
F |
75871 |
1540 |
Crl:SD |
water drink intake rate |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
drinking behavior trait |
male |
63 days-77 days |
9 |
39.0 |
ml/d |
0.7 |
2.1 |
unspecified method |
|
0.0 |
0 |
F |
75863 |
1540 |